Paladin Partners’s Cardinal Health CAH Stock Holding History

Paladin Partners’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.75K	Hold	20	–	–	﹤0.01%	160
2026 Q1	$4.23K	Hold	20	–	–	﹤0.01%	163
2025 Q4	$4.11K	Buy	+20	New	+$3.76K	﹤0.01%	164

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Paladin Partners's CAH Position: Q2 2026 in Review

Paladin Partners held its Cardinal Health (CAH) position steady in Q2 2026 at 20 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #160.

Paladin Partners first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Paladin Partners held 20 shares of Cardinal Health worth $4.75K as of Q2 2026.
Paladin Partners left its Cardinal Health share count unchanged in Q2 2026.
Cardinal Health made up ﹤0.01% of Paladin Partners's portfolio in Q2 2026, its #160 holding.
Paladin Partners first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Paladin Partners's 13F filing for Q2 2026, filed 7 Aug 2026.